Share
Journal Information
Most often read
2523
SEA 2022 standards for the comprehensive control of cardiovascular riskJ.M. Mostaza, X. Pintó, P. Armario, L. Masana, J.T. Real, P. Valdivielso, T. Arrobas-Velilla, R. Baeza-Trinidad, ... L. Vila
Clin Investig Arterioscler. 2022;34:130-79
2523
Open access
Open Article
1648
Inflammation and atherogenic markers in patients with type 2 diabetes mellitusMaría Aurora Maravilla Domínguez, María de Lourdes Zermeño González, Elias Roberto Zavaleta Muñiz, Verónica Adriana Montes Varela, Cesar Antonio Irecta Nájera, Nicté Selene Fajardo Robledo, Soraya Amalí Zavaleta Muñiz
Clin Investig Arterioscler. 2022;34:105-12
1648
Open Article
1390
Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021)Francisco Arrieta, Juan Pedro-Botet, Pedro Iglesias, Juan Carlos Obaya, Laura Montanez, Gonzalo Fernando Maldonado, Antonio Becerra, Jorge Navarro, ... Manuel Aguilar
Clin Investig Arterioscler. 2022;34:36-55
1390
Open Article
1352
Adherence to non-pharmacological treatment is associated with the goals of cardiovascular control and better eating habits in Mexican patients with type 2 diabetes mellitusLubia Velázquez-López, Paulina Segura Cid del Prado, Eloísa Colín-Ramírez, Abril Violeta Muñoz-Torres, Jorge Escobedo-de la Peña
Clin Investig Arterioscler. 2022;34:88-96
1352
Open Article
1216
HDL-cholesterol concentration and risk of SARS-CoV-2 infection in people over 75 years of age: A cohort with half a million participants from the Community of MadridCarlos Lahoz, Miguel A. Salinero-Fort, Juan Cárdenas, Fernando Rodríguez-Artalejo, Mariana Díaz-Almiron, Pilar Vich-Pérez, F. Javier San Andrés-Rebollo, Ignacio Vicente, José M. Mostaza
Clin Investig Arterioscler. 2022;34:113-9
1216
Open Article
970
Situation in 2020 of the requirements for the use of PCSK9 inhibitors in Spain: Results of a national surveyCarlos Guijarro, Fernando Civeira, José López-Miranda, Luis Masana, Juan Pedro-Botet, Xavier Pintó, Pedro Valdivielso, José María Mostaza
Clin Investig Arterioscler. 2022;34:10-8
970
Open access
Open Article
833
Application of the individualized objectives defined by the European 2019 lipid guidelines in patients with type 2 diabetesDavid Martín Enguix, Abraham Hidalgo Rodríguez, María Sánchez Cambronero, Juan Carlos Aguirre Rodríguez
Clin Investig Arterioscler. 2022;34:19-26
833
Open Article
766
Challenges and perspectives of the double burden of malnutrition in Latin AmericaÁngela Hernández-Ruiz, Casandra Madrigal, María José Soto-Méndez, Ángel Gil
Clin Investig Arterioscler. 2022;34 Supl 1:3-16
766
Open Article
714
Bempedoic acid as a PPARα activator: New perspectives for hepatic steatosis treatment in a female rat experimental modelRoger Bentanachs, Ana Magdalena Velázquez, Rosa María Sánchez, Marta Alegret, Juan Carlos Laguna, Núria Roglans
Clin Investig Arterioscler. 2022;34:57-67
714
Open Article
617
Update on new forms of tobacco useJorge Francisco Gómez Cerezo, José Enrique López Paz, Jacinto Fernández Pardo
Clin Investig Arterioscler. 2022;34:330-8
617
Open access
Open Article
567
Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!Niki Katsiki, Anca Pantea Stoian, Manfredi Rizzo
Clin Investig Arterioscler. 2022;34 Supl 1:23-30
567
Open Article
545
Dyslipidemia observatory: Treatment of hypercholesterolemia in Spain, context and levers for improvement in clinical practiceJuan Cosín-Sales, Raquel Campuzano Ruiz, José Luis Díaz Díaz, Carlos Escobar Cervantes, María Rosa Fernández Olmo, Juan José Gómez-Doblas, José María Mostaza, Juan Pedro-Botet, ... Pedro Valdivielso
Clin Investig Arterioscler. 2022;34:253-60
545
Open Article
500
Familial chylomicronemia syndrome: The first case reported in EcuadorKarla Johana Garay García, Ricardo Javier Chong Menendez, Juan Patricio Nogueira, Jefferson Santiago Piedra Andrade
Clin Investig Arterioscler. 2022;34:326-9
500
Open Article
477
Relationship between the coronary artery calcium quantification and gut microbiota composition in subjects without previous cardiovascular disease: A pilot studyIsabel Ortega-Madueño, Javier Modrego, Rubén Gómez-Gordo, Adriana Ortega-Hernández, Leopoldo Pérez de Isla, Juan Carlos Muñoz, M. Luisa Nieto, Dulcenombre Gómez-Garre
Clin Investig Arterioscler. 2022;34:205-15
477
Open Article
458
Why are brown bears protected against atherosclerosis even though their plasma cholesterol levels are twice that of humans?Eva Hurt-Camejo, Matteo Pedrelli
Clin Investig Arterioscler. 2022;34:322-5
458
Open access
Open Article
406
Prevalence rates of overweight and obesity and their associations with cardiometabolic and renal factors. SIMETAP-OB studyAntonio Ruiz-García, Ezequiel Arranz-Martínez, Luis Enrique Morales-Cobos, Juan Carlos García-Álvarez, Nerea Iturmendi-Martínez, Montserrat Rivera-Teijido
Clin Investig Arterioscler. 2022;34:291-302
406
Open Article
371
The future of diet: what will we be eating in The future?Francisco Pérez-Jiménez
Clin Investig Arterioscler. 2022;34 Supl 1:17-22
371
Open Article
370
DNA methylation pattern of hypertriglyceridemic subjectsMontse Guardiola, Daiana Ibarretxe, Núria Plana, Lluís Masana, Josep Ribalta
Clin Investig Arterioscler. 2022;34:27-32
370
Open Article
362
Prevalence of prediabetes and association with cardiometabolic and renal factors. SIMETAP-PRED studyEzequiel Arranz-Martínez, Antonio Ruiz-García, Juan Carlos García Álvarez, Teresa Fernández Vicente, Nerea Iturmendi Martínez, Montserrat Rivera-Teijido
Clin Investig Arterioscler. 2022;34:193-204
362
Open Article
348
Impact of the complex humanitarian crisis on the epidemiology of the cardiometabolic risk factors in VenezuelaJuan P. González-Rivas, Jeffrey I. Mechanick, Carlos Ponte, Diana de Oliveira-Gomes, Rocio Iglesias-Fortes, Livia Machado, Maritza Duran, Maria Inés Marulanda, Ramfis Nieto-Martínez
Clin Investig Arterioscler. 2022;34:97-104
348
Open Article